DK1715859T3 - Fremgangsmåde til behandling og diagnosticering af åndedrætsforstyrrelser i sövnen ved hjælp af zonisamid og midler til at gennemföre fremgangsmåden - Google Patents
Fremgangsmåde til behandling og diagnosticering af åndedrætsforstyrrelser i sövnen ved hjælp af zonisamid og midler til at gennemföre fremgangsmådenInfo
- Publication number
- DK1715859T3 DK1715859T3 DK05711057T DK05711057T DK1715859T3 DK 1715859 T3 DK1715859 T3 DK 1715859T3 DK 05711057 T DK05711057 T DK 05711057T DK 05711057 T DK05711057 T DK 05711057T DK 1715859 T3 DK1715859 T3 DK 1715859T3
- Authority
- DK
- Denmark
- Prior art keywords
- zonisamide
- treating
- osa
- sleep
- carrying
- Prior art date
Links
- UBQNRHZMVUUOMG-UHFFFAOYSA-N zonisamide Chemical compound C1=CC=C2C(CS(=O)(=O)N)=NOC2=C1 UBQNRHZMVUUOMG-UHFFFAOYSA-N 0.000 title abstract 5
- 229960002911 zonisamide Drugs 0.000 title abstract 5
- 238000000034 method Methods 0.000 title abstract 3
- 208000023504 respiratory system disease Diseases 0.000 title 1
- 208000001797 obstructive sleep apnea Diseases 0.000 abstract 4
- 238000004519 manufacturing process Methods 0.000 abstract 2
- 238000003745 diagnosis Methods 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 210000003097 mucus Anatomy 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
- 230000029058 respiratory gaseous exchange Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/423—Oxazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Emergency Protection Circuit Devices (AREA)
- Test And Diagnosis Of Digital Computers (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0400378A SE0400378D0 (sv) | 2004-02-17 | 2004-02-17 | Sätt att behandla och diagnostisera andningsstörningar i sömnen och medel för att utföra sättet |
| PCT/SE2005/000196 WO2005077362A1 (en) | 2004-02-17 | 2005-02-15 | Method of treating and diagnosing sleep disordered breathing using zonisamide and means for carrying out the method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1715859T3 true DK1715859T3 (da) | 2009-02-16 |
Family
ID=31974257
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK05711057T DK1715859T3 (da) | 2004-02-17 | 2005-02-15 | Fremgangsmåde til behandling og diagnosticering af åndedrætsforstyrrelser i sövnen ved hjælp af zonisamid og midler til at gennemföre fremgangsmåden |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US7655681B2 (da) |
| EP (1) | EP1715859B1 (da) |
| JP (1) | JP2007523079A (da) |
| CN (1) | CN100558358C (da) |
| AT (1) | ATE410163T1 (da) |
| AU (1) | AU2005212149B2 (da) |
| CA (1) | CA2555149C (da) |
| DE (1) | DE602005010213D1 (da) |
| DK (1) | DK1715859T3 (da) |
| ES (1) | ES2317196T3 (da) |
| NZ (1) | NZ548943A (da) |
| SE (1) | SE0400378D0 (da) |
| SI (1) | SI1715859T1 (da) |
| WO (1) | WO2005077362A1 (da) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101167579B1 (ko) | 2003-04-29 | 2012-07-27 | 오렉시젠 세러퓨틱스 인크. | 체중감량용 조성물 |
| EP1928445A1 (en) * | 2005-09-16 | 2008-06-11 | Cereuscience AB | Method and means of preventing and treating sleep disordered breathing |
| PT2135603E (pt) | 2005-11-22 | 2013-04-03 | Orexigen Therapeutics Inc | Composições e métodos para aumentar a sensibilidade à insulina |
| PL1954241T3 (pl) * | 2005-11-28 | 2013-03-29 | Orexigen Therapeutics Inc | Formulacja zonisamidu o przedłużonym uwalnianiu |
| US8916195B2 (en) | 2006-06-05 | 2014-12-23 | Orexigen Therapeutics, Inc. | Sustained release formulation of naltrexone |
| WO2008060964A2 (en) | 2006-11-09 | 2008-05-22 | Orexigen Therapeutics, Inc. | Unit dosage package and methods for administering weight loss medications |
| CA2725930A1 (en) | 2008-05-30 | 2009-12-30 | Orexigen Therapeutics, Inc. | Methods for treating visceral fat conditions |
| EP2521546A4 (en) * | 2010-01-07 | 2013-06-26 | Vivus Inc | TREATMENT OF THE OBSTRUCTIVE SLEEP APNEO SYNDROME COMBINED WITH ANTIBODY ANTIBODY AND AN ADDITIONAL ACTIVE SUBSTANCE |
| ES2762113T3 (es) | 2010-01-11 | 2020-05-22 | Nalpropion Pharmaceuticals Inc | Métodos de proporcionar terapia de pérdida de peso en pacientes con depresión mayor |
| AU2013270443B2 (en) * | 2012-05-30 | 2016-10-13 | Resmed Sensor Technologies Limited | Method and apparatus for monitoring cardio-pulmonary health |
| PL4104824T3 (pl) | 2012-06-06 | 2025-11-12 | Nalpropion Pharmaceuticals Llc | Kompozycja do zastosowania w sposobie leczenia nadwagi i otyłości u pacjentów z wysokim ryzykiem sercowo-naczyniowym |
| US10525219B2 (en) | 2012-06-26 | 2020-01-07 | Resmed Sensor Technologies Limited | Methods and apparatus for monitoring and treating respiratory insufficiency |
| CA3016110C (en) | 2016-05-11 | 2020-09-01 | Jan Hedner | Sultiame for the treatment of sleep apnea |
| CN112259179A (zh) * | 2020-10-09 | 2021-01-22 | 首都医科大学宣武医院 | 一种患者日志生成方法及装置 |
| US20240306982A1 (en) * | 2023-03-16 | 2024-09-19 | Laura Schneider | Method for treating sleep apnea/hypopnea |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6489350B1 (en) * | 1999-09-15 | 2002-12-03 | Elan Pharmaceuticals, Inc. | Methods for treating neuropathic pain using heteroarylmethanesulfonamides |
| SE0000601D0 (sv) * | 2000-02-24 | 2000-02-24 | Jan Hedner | Sätt att behandla och diagnostisera andningsstörningar i sömnen och medel för att utföra sättet |
| AU2003231788B2 (en) * | 2002-05-17 | 2008-09-11 | Duke University | Method for treating obesity |
-
2004
- 2004-02-17 SE SE0400378A patent/SE0400378D0/xx unknown
-
2005
- 2005-02-15 SI SI200530544T patent/SI1715859T1/sl unknown
- 2005-02-15 DE DE602005010213T patent/DE602005010213D1/de not_active Expired - Lifetime
- 2005-02-15 JP JP2006553094A patent/JP2007523079A/ja active Pending
- 2005-02-15 ES ES05711057T patent/ES2317196T3/es not_active Expired - Lifetime
- 2005-02-15 AU AU2005212149A patent/AU2005212149B2/en not_active Ceased
- 2005-02-15 US US10/598,114 patent/US7655681B2/en not_active Expired - Lifetime
- 2005-02-15 CN CNB2005800049089A patent/CN100558358C/zh not_active Expired - Fee Related
- 2005-02-15 NZ NZ548943A patent/NZ548943A/en not_active IP Right Cessation
- 2005-02-15 WO PCT/SE2005/000196 patent/WO2005077362A1/en not_active Ceased
- 2005-02-15 EP EP05711057A patent/EP1715859B1/en not_active Expired - Lifetime
- 2005-02-15 DK DK05711057T patent/DK1715859T3/da active
- 2005-02-15 CA CA2555149A patent/CA2555149C/en not_active Expired - Fee Related
- 2005-02-15 AT AT05711057T patent/ATE410163T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1715859B1 (en) | 2008-10-08 |
| US20070281005A1 (en) | 2007-12-06 |
| WO2005077362A1 (en) | 2005-08-25 |
| SI1715859T1 (sl) | 2009-06-30 |
| CN100558358C (zh) | 2009-11-11 |
| CA2555149C (en) | 2014-01-21 |
| US7655681B2 (en) | 2010-02-02 |
| NZ548943A (en) | 2010-06-25 |
| CA2555149A1 (en) | 2005-08-25 |
| SE0400378D0 (sv) | 2004-02-17 |
| EP1715859A1 (en) | 2006-11-02 |
| ATE410163T1 (de) | 2008-10-15 |
| CN1917874A (zh) | 2007-02-21 |
| AU2005212149A1 (en) | 2005-08-25 |
| JP2007523079A (ja) | 2007-08-16 |
| ES2317196T3 (es) | 2009-04-16 |
| DE602005010213D1 (de) | 2008-11-20 |
| AU2005212149B2 (en) | 2010-02-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SI1715859T1 (sl) | Postopek za zdravljenje in diagnosticiranje motenega dihanja med spanjem z uporabo zonisamida in sredstvo za izvedbo postopka | |
| SG169233A1 (en) | Pharmaceutical compositions comprising apomorphine for pulmonary inhalation | |
| EA200800663A1 (ru) | Способ и средство профилактики и лечения нарушенного дыхания во время сна | |
| WO2008022189A3 (en) | Administration of high potency platinum compound formulations by inhalation | |
| JP2009539961A5 (da) | ||
| DE602005018763D1 (de) | Dopamin-agonisten-kombinationstherapie mit sedativa zur verbesserung der schlafqualität | |
| MX2012007813A (es) | Tratamiento del sindrome de apnea obstructiva del sueño con una combinacion de un hinibidor de anhidrasa carbonica y un agente activo adicional. | |
| UA107578C2 (uk) | Комбінована терапія при лікуванні діабету | |
| JP2009537553A5 (da) | ||
| EA200700214A1 (ru) | Мемантин в качестве дополнительной терапии к атипичным антипсихотическим средствам у больных шизофренией | |
| PT2111868E (pt) | Utilização de albumina humana terapêutica na preparação de um medicamento para o tratamento de doentes sofrendo de distúrbios cognitivos | |
| MX2009011900A (es) | Curacion de herida diabetica. | |
| DE502005010170D1 (de) | Neue langwirksame beta-2-agonisten, und deren verwendung als arzneimittel | |
| Giannasi et al. | Efficacy of an oral appliance for the treatment of obstructive sleep apnea. | |
| SE0000601D0 (sv) | Sätt att behandla och diagnostisera andningsstörningar i sömnen och medel för att utföra sättet | |
| NO20054767L (no) | Sammensetninger omfattende apomorfin for inhalering i lunge | |
| NO20064964L (no) | Behandling av svekket respiratorisk funksjon | |
| EA200701077A1 (ru) | Применение конъюгатов липидов при лечении заболеваний | |
| WO2005110052A3 (en) | The use of inhaled gaseous nitric oxide as a mucolytic agent or expectorant | |
| JP2010523662A5 (da) | ||
| RU2009141168A (ru) | Способы и композиции, содержащие дезвенлафаксин или дулоксетин, для лечения расстройств дыхания во время сна | |
| NO20091659L (no) | Fremgangsmater for behandling av disruptive oppforselsforstyrrelser | |
| MXPA04002401A (es) | Nuevos medicamentos para inhalacion. | |
| BR0311180A (pt) | Métodos para o tratamento de doenças e condições respiratórias utilizando um inibidor seletivo da inos | |
| IS8373A (is) | Notkun oxkarbasepíns til að meðhöndla sársauka vegna sykursýkisfjöltauga-kvilla og til að bæta svefn |